Does glutamate influence myocardial and peripheral tissue metabolism after aortic valve replacement for aortic

Farkas B Vánky1, Erik Håkanson, Lennart Jorfeldt

  • 1Department of Cardiothoracic Surgery, Linköping Heart Centre, University Hospital, SE-581 85 Linköping, Sweden.

Insights

Postoperative glutamate infusion increased tissue uptake of glutamate in patients undergoing aortic stenosis surgery. This suggests potential benefits for myocardial and peripheral tissue metabolism after cardiac procedures.

Area of Science:

  • Cardiology
  • Metabolic Research
  • Surgical Science

Background:

  • Glutamate is crucial for myocardial metabolism, especially during ischemia.
  • Patients with coronary artery disease show increased glutamate uptake.
  • Previous studies suggest glutamate infusion improves recovery after coronary surgery.

Purpose of the Study:

  • To investigate the effects of glutamate on myocardial and peripheral tissue metabolism after aortic stenosis surgery.
  • To assess glutamate's impact on tissue metabolism in a surgical context beyond coronary artery disease.

Main Methods:

  • A randomized, double-blind study involving 20 patients undergoing aortic stenosis surgery.
  • Patients received either glutamate or saline infusion post-surgery.
  • Myocardial and leg tissue metabolism were evaluated using organ balance techniques.

Main Results:

  • Glutamate infusion significantly increased glutamate uptake in both myocardial and leg tissues.
  • A notable uptake of lactate by the heart was observed post-glutamate infusion.
  • Peripheral tissue metabolism showed reduced uptake of amino acids and free fatty acids in the glutamate group, indicating altered substrate utilization.

Conclusions:

  • The heart and peripheral tissues actively consumed administered glutamate following aortic stenosis surgery.
  • These findings suggest potentially beneficial effects of glutamate on both cardiac and peripheral tissue metabolism in the postoperative setting.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...